These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2523264)

  • 1. Acute hormonal and renal effects of oral dilevalol in normal men.
    Whitworth JA; Gordon D; Harpley R; Yeung S; Phillips P
    Clin Exp Pharmacol Physiol; 1989 Jan; 16(1):59-63. PubMed ID: 2523264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects.
    Fujimura A; Ohashi K; Tsuru M; Ebihara A; Kondo K
    J Clin Pharmacol; 1989 Jul; 29(7):635-42. PubMed ID: 2668352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.
    Baba T; Murabayashi S; Aoyagi K; Ishizaki T
    Eur J Clin Pharmacol; 1988; 35(1):9-15. PubMed ID: 2905992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intravenous dilevalol with placebo in moderate hypertension.
    Winer N; Blasucci DJ; Medakovic M
    Clin Pharmacol Ther; 1989 Oct; 46(4):445-50. PubMed ID: 2551560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise.
    Bellissant E; Annane D; Thuillez C; Giudicelli JF
    Eur J Clin Pharmacol; 1994; 47(1):39-47. PubMed ID: 7988622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertension.
    Grossman E; Messerli FH; Oren S; MacPhee AA
    Am J Cardiol; 1989 Jun; 63(19):34I-37I. PubMed ID: 2524958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.
    Maack T; Marion DN; Camargo MJ; Kleinert HD; Laragh JH; Vaughan ED; Atlas SA
    Am J Med; 1984 Dec; 77(6):1069-75. PubMed ID: 6239544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
    Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans.
    Oelkers W; Kleiner S; Bähr V
    Hypertension; 1988 Oct; 12(4):462-7. PubMed ID: 2971619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly.
    Clifton GG; Cook ME; Poland M; Wallin JD
    J Clin Pharmacol; 1989 Jul; 29(7):603-8. PubMed ID: 2760254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level and diurnal variations of hormones of interest to the cardiovascular system in patients with heart transplants.
    Sehested J; Thomas F; Thorn M; Schifter S; Regitz V; Sheikh S; Oelkers W; Palm U; Meyer-Sabellek W; Hetzer R
    Am J Cardiol; 1992 Feb; 69(4):397-402. PubMed ID: 1531162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activity.
    Wallin JD; Frishman WH
    J Clin Pharmacol; 1989 Dec; 29(12):1057-68. PubMed ID: 2693499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects.
    Portaluppi F; Bagni B; degli Uberti E; Montanari L; Cavallini R; Trasforini G; Margutti A; Ferlini M; Zanella M; Parti M
    J Hypertens; 1990 Jan; 8(1):85-95. PubMed ID: 2157761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Eur J Clin Pharmacol; 1990; 38(3):305-7. PubMed ID: 2187701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man.
    Weidmann P; Hellmueller B; Uehlinger DE; Lang RE; Gnaedinger MP; Hasler L; Shaw S; Bachmann C
    J Clin Endocrinol Metab; 1986 May; 62(5):1027-36. PubMed ID: 2937799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of dilevalol (II). The pharmacokinetic, pharmacodynamic, and tolerance studies of dilevalol during repeated administration in healthy subjects.
    Fujimura A; Ohashi K; Tsuru M; Ebihara A; Kondo K
    J Clin Pharmacol; 1989 Jul; 29(7):643-9. PubMed ID: 2760257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG
    Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilevalol: a dose-response study in normal volunteers.
    Walden RJ; Graham BR; Liu JB; Prichard BN
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():69-75. PubMed ID: 2196371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.
    Walley T; Tsao Y; Scott A; Mackay E; Vandenburg M; Breckenridge A
    Br J Clin Pharmacol; 1993 Jun; 35(6):623-8. PubMed ID: 8329290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.